(1063 \m=+-\437 pg/mg, mean \ m=+-\se), small amounts of immunnoreactive \g=a\-neoendorphin(22.6 \ m=+-\6.4 pg/mg) and dynorphin (8.5 \m=+-\ 1.2 pg/mg) were detected in all seventeen human phaeochromocytomas and the two human adrenal medullas. Leumorphin-like immunoreactivity was detected in only four tumours. Gel chromatographic studies revealed the presence of preproenkephalin B-derived peptides and their high molecular forms. A significant positive correlation between the tumour tissue contents of immunoreactive \g=a\-neoendorphin and of dynorphin was observed. Nicotine (10\m=-\5,10\ m=-\ 4 mol/l) significantly stimulated the secretion of immunoreactive \g=a\-neoendorphin and dynorphin as well as leuenkephalin and catecholamines from cultured human phaeochromocytoma cells. Administration of 1 mg of glucagon to a patient with medullary phaeochromocytoma induced a rapid increase in the plasma concentration of immunoreactive \g=a\-neoendorphin with a concomitant increase in plasma catecholamines. These results indicate the presence of preproenkephalin B-derived (Noda et al. 1982; Gubler et al. 1982 ) and a human phaeochromocytoma (Comb et al. 1982) . The precursor sequences of ct-neoendorphin (Kangawa et al. 1979 ) and dynor¬ phin (Goldstein et al. 1981) , namely preproenke¬ phalin has recently been clarified from nucleo¬ tide analysis of cloned hypothalamic mRNA, and a third leu-enkephalin sequence, leumorphin, has newly been designated (Kakidani et al. 1982) . Leu-enkephalin could be derived from both pre¬ proenkephalin A and B. Despite their remarkable potent opioid activity (Kangawa et (Ghazarossian et al. 1980 ). Standard -neoendorphin and specific anti¬ serum for -neoendorphin (Minamino et (GIBCO) supplemented with 10% foetal calf serum (GIBCO).
The cells were incubated at 37°C in 5% C02-95% air.
The media were daily renewed and the experiments were initiated 3 days after plating. Before the addition of nicotine, each plate was washed at 37°C for 5 min in 1.0 ml of Hepes-buffered Krebs-Ringer saline (KRH) containing 0.2% bovine serum albumin (BSA) and then exchanged with 1.0 ml of KRH containing 2 mmol/1 CaCl2 and 5 x 10"5 mol/1 Bacitracin (Sigma). There¬ after, 10"5 or 1()"4 mol/1 nicotine was added to each plate. After (Ueda et al. 1977) . The sensitivity of the assay was endorphin, and leumorphin with other opioid peptides are precisely described in the respective original papers (Ghazarossian et al. 1980; Minamino et al. 1981; Nakamura et al. 1985) . In summary, an antiserum for leuenkephalin cross-reacted 5% with met-enkephalin and less than 0.1% with other peptides, including a-neo¬ endorphin, dynorphin (1-13),'and human leumorphin. The respective antiserums for -neoendorphin, dynor¬ phin (1-13), and human leumorphin showed no signifi¬ cant cross-reactivity with each other or with leu-enke¬ phalin (< 0.1% ). An antiserum for dynorphin (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) cross-reacted 100% with complete sequence of dynor¬ phin (1-17) isolated as endogenous procine pituitary dynorphin (Goldstein et al. 1981 ). An antiserum for human leumorphin mainly recognized the C-terminal peptides of human leumorphin and cross-reacted 78% with human leumorphin (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , however it showed no cross with rimorphin (leumorphin 1-13) isolated from posterior pituitary glands (Kilpatrick et al. 1982) . The sensitivities of these RIAs were 3-6 pg/tube. We could confirm the increase in plasma im¬ munoreactivity of -neoendorphin following glu¬ cagon administration in a patient with medullary phaeochromocytoma. Concomitant increases in the immunoreactivity of met-enkephalin and of leu-enkephalin in plasma following glucagon ad¬ ministration was reported by Yoshimasa et al. (1983) . Preproenkephalin B-derived peptides are secreted from human phaeochromocytomas and may have some physiological roles in peripheral tissues, including the inhibitory effect on catechol¬ amine secretion from human Ph cells (Yanase et al. 1986 ).
In summary, we showed the presence of prepro¬ enkephalin B-derived opioid peptides in human phaeochromocytomas and human adrenal medul¬ las and their secretion in human phaeochromo¬ cytomas.
